Health care Devices Market

  The global “ digestive health market ” size is expected to reach USD 71.95 billion by 2027, exhibiting a CAGR of 7.9% during the forecast period. The growing awareness regarding the prominence of dietary supplements, probiotics, and functional will have a tremendous impact on the the market, states Fortune Business Insights, in a report, titled “Digestive Health Market Size, Share & COVID-19 Impact Analysis, By Ingredient Type (Probiotics, Prebiotics, Digestive Enzymes/Food Enzymes, and Others), By Product Type (Functional Foods & Beverages, Vitamins & Dietary Supplements, and Others), By Distribution Channel (Supermarkets/Hypermarkets, Hospital Pharmacies, Online Pharmacies, and Others), and Regional Forecast, 2020-2027.” The market size stood at USD 37.93 billion in 2019. The coronavirus incident has caused massive loss and disruption to various industries across the globe. We understand that this health disaster has negatively impacted various sectors across the globe.

  The global “ ophthalmic diagnostic devices market ” is set to gain traction from the ever-increasing awareness programs regarding various ocular disorders and diseases. It is mainly occurring because of the rising initiatives by the government and non-government organizations to educate the masses about ocular health. Besides, the populaces worldwide are utilizing the wide range of available online resources and tools to get to know more about such types of disorders and their diagnosis. Fortune Business Insights™ provided the information mentioned above in a report, titled, “Ophthalmic Diagnostic Devices Market Size, Share & Industry Analysis, By Product Type (Optical Coherence Tomography, Aberrometer & Topography Systems, Fundus Camera, Ophthalmic Ultrasound, and Other Ophthalmic Devices), By End-user (Hospitals, Ophthalmic Clinics, Others), and Regional Forecast, 2019-2026.” As per the report, the ophthalmic diagnostic devices market size stood at USD 2.41 billion in 2018.

  The increasing need for effective waste management is a key factor driving the global “ sharps containers market ”, says Fortune Business Insights in a report, titled “Sharps Containers Market Size, Share & Industry Analysis, By Product Type (Multipurpose Containers, Patient Room Containers, Phlebotomy Containers), By Waste Generators (Hospitals, Other Healthcare Providers, Pharmacies, Academic & Research Institutes, Pharmaceutical Companies, and Others), By Usage (Reusable Containers, and Single Use Containers), By Waste Type (Sharps Waste, Infectious Waste, Non-infectious Waste, and Pharmaceutical Waste), By Size (1–2 Gallons, 2–4 Gallons, 4–8 Gallons and Others) and Regional Forecast, 2019-2026.” The global sharps containers market was valued at USD 449.1 Million in 2018 and is expected to reach USD 624.1 Million by 2026 at a CAGR of 4.2%.As per the report, the rising awareness regarding hazardous waste is expected to aid the growth of the global sharps containers market.

  The increasing prevalence of chronic diseases among the geriatric population is driving the “ Netherlands home healthcare market ”. The above information is published in a report, titled “Netherlands Home Healthcare: Market Analysis, Insights and Forecast, 2019-2026.” Fortune Business Insights in the report predicts that rising geriatric population in the Netherlands is leading to high demand for home healthcare equipment. A study by Central Bureau Statistics (CBU), it is estimated that around 3.31 million people in the Netherlands are aged above 65 years. Also, the study predicts that the number will increase by 2026. This further indicates that the adoption of home healthcare products will increase in the forthcoming years. As per the report by Fortune Business Insights, the Netherlands market was worth US$ 570.0 Mn in 2018 and is anticipated to reach US$ 1013.1 Mn by 2026. As home healthcare is a viable option and increasingly adopted by the elderly population, the market for home

  The global “ hepatitis C drugs market ” will derive growth impetus from the high prevalence of hepatitis C across the world. According to a report published by Fortune Business Insights, titled “Hepatitis C Drugs: Global Market Analysis, Insights and Forecast, 2019-2026,” the market was valued at US$ 7,866.6 Mn in 2018. Fortune Business Insights states that the market is projected to reach US$ 7,351.7 Mn by 2026, exhibiting a CAGR of -0.9% in the forecast period. Hepatitis C requires oral injections and dosages on a weekly basis, and it also has several side effects that can also lead to permanent damage. Increasing clinical trials and successful drug clearances have aided the overall growth of the global hepatitis C market. Increasing number of regulatory approvals will boost the global hepatitis C market in the forthcoming years. Hepatitis C is a viral infection that causes severe damage such as inflammation of the liver and can spread through contaminated blood. The advanced stage

  The global “ leukemia therapeutics market ” size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of   8.1%  during the forecast period. The increasing demand for enhanced treatments for blood cancers amid the COVID-19 pandemic will accelerate the market, states Fortune Business Insights™ in its report, titled “Leukemia Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Type of Leukemia (Chronic Myeloid Leukemia (CML), Chronic Lymphocytic Leukemia (CLL), Acute Lymphocytic Leukemia (ALL), Acute Myeloid Leukemia (AML), and Others), By Treatment Type (Chemotherapy, Targeted Therapy, Immunotherapy, and Others), By Route of Administration (Oral Mode and Injectable Mode), By Distribution Channels (Hospital Pharmacy, Retail Pharmacy, and Others), and Regional Forecast, 2020-2027”. Cancer patients are at a heightened risk of contracting the coronavirus and likely to experience severe effects of the infection due to their weakened immune systems. According to

  The global “ transplantation market ” size is expected to reach USD 14.67 billion by 2028, exhibiting a CAGR of 10.6% during the forecast period. The increasing awareness regarding organ donations coupled with government initiatives can have an excellent impact on the global market in the forthcoming years, states Fortune Business Insights, in a report, titled “Transplantation Market, 2021-2028.” The market size stood at USD 5.47 billion in 2020. An Overview of the Impact of COVID-19 on this Market The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this too shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. There are some industries that are struggling and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic. We are taking continuous effort

  The global “ stomach cancer treatment ” market size is expected to reach USD 8.20 billion by 2026, exhibiting a CAGR of 15.3% during the forecast period. One of the major forces behind the rise of this market is the increasing prevalence of cancer in general and stomach cancer in particular worldwide. The GLOBOCAN 2018, which is a report on the global burden of cancer produced by the International Agency for Research on Cancer (IARC), estimates that in 2018, new cancer cases will be around 18 million and cancer-related deaths will be close to 9.6 million. Further, stomach cancer will account for 8.2% of the new cancer cases. Statistics released by the World Cancer Research Fund (WCRF) substantiate the IARC’s findings. According to the WCRF, gastric cancer is the fourth mostly commonly diagnosed cancer worldwide, with 1 million new reported cases. As the incidence of stomach cancer increases across the globe, the demand for stomach cancer drugs will rise commensurately, spelling good

  The global “ non-steroidal anti-inflammatory drugs ” market is set to gain momentum from the ever-increasing research activities by several prominent pharmaceutical companies on selective cyclooxygenase-2 inhibitors as they are still a grey area for these companies. Tough, Non-steroidal Anti-Inflammatory Drugs such as ibuprofen and diclofenac are nowadays used to hinder the activity of COX, but they have undesirable effect. Fortune Business Insights™ published this information in a new report, titled, “Non-steroidal Anti-Inflammatory Drugs (Non-steroidal Anti-Inflammatory Drugs) Market Size, Share & Industry Analysis, By Disease Indication (Arthritis, Migraine, Ophthalmic Diseases, and Others), By Route of Administration (Oral, and Parenteral), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.” The report further mentions that the Non-Steroidal Anti-Inflammatory Drugs market size was USD 15.58 billion in 2019 and i

  Global   Lymphoma Treatment Market   | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Lymphoma Treatment Industry, published by Fortune Business Insights. According to this report Global Lymphoma Treatment Market to rise at healthy Compound Annual Growth Rate by 2028. Market for Lymphoma Treatment Industry is segmented By Product Type (Lymphoma Treatment Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2019-2026 Major Lymphoma Treatment Manufacturers covered in the market report include: Takeda Pharmaceutical Company Limited AstraZeneca Bayer AG Novartis AG Kite Pharma, Inc. / Gilead Sciences, Inc. Spectrum Pharmaceuticals, Inc. Teva Pharmaceutical Industries Ltd. Bristol Myers Squibb Company Janssen Pharmaceuticals, Inc. Get Sample PDF Brochure of Lymphoma Treatment Market Report at: https://www.fortunebusinessinsights.com/enquir

  Global   Ophthalmic Diagnostic Devices   Market | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Ophthalmic Diagnostic Devices Industry, published by Fortune Business Insights. According to this report Global Ophthalmic Diagnostic Devices Market to rise at healthy Compound Annual Growth Rate by 2028. Market for Ophthalmic Diagnostic Devices Industry is segmented By Product Type (Ophthalmic Diagnostic Devices Frames and Spectacle Lenses), By Modality (Prescription and Over-the-counter) By Distribution Channel (Retail Store, Online Store, Ophthalmic Clinics), and Regional Forecast, 2019-2026 Major Ophthalmic Diagnostic Devices Manufacturers covered in the market report include: Optovue, Incorporated ZEISS International AMETEK, Inc. Alcon NIDEK CO., LTD. Essilor TOPCON HAAG-STREIT GROUP Other prominent players Hologic, Inc. and other key market players. Get Sample PDF Brochure Of Ophthalmic Diagnostic Devices Market Report at: https://www.fortunebusinessins